Published by Frank Prenesti on 5th February 2025
(Sharecast News) - Novo Nordisk reported better-than-expected fourth quarter profit on the back of surging demand for its Wegovy weight loss drug but also said 2025 sales growth would slow slightly as competition for obesity treatments intensified.
URL: http://www.digitallook.com/dl/news/story/34860445/...